SCHEDULE: ClearOne Inc. Filing: Warrant Cancellation Amidst Merger

ClearOne Inc. reports the cancellation of a warrant by First Finance Ltd. as part of a merger agreement, maintaining a significant ownership stake.

Summary

• This filing is an amendment (Amendment No. 3) to a Schedule 13D, reporting the cancellation of a warrant by First Finance Ltd. concerning ClearOne, Inc. (the Issuer).
• First Finance Ltd. previously acquired 437,500 shares and a warrant to purchase an additional 437,500 shares on March 2, 2026, for $1,750,000.
• On August 4, 2026, First Finance Ltd. surrendered and cancelled this warrant for no consideration, as part of a merger agreement involving the Issuer, CLRO Merger Sub, Inc., Cortigent, Inc., and Vivani Medical, Inc.
• The merger involves CLRO Merger Sub, Inc. merging with Cortigent, Inc., with Cortigent surviving as a subsidiary of the Issuer. Vivani Medical, Inc. will receive 12,500,000 shares of the Issuer's common stock as consideration.
• As of August 5, 2026, First Finance Ltd. directly owns 1,641,162 shares of the Issuer's common stock, representing approximately 61.3% of the outstanding shares.
• Andrew Hromyk beneficially owns the same 1,641,162 shares due to his pecuniary interest in First Finance Ltd., also representing approximately 61.3% of the common stock.
• Following the warrant cancellation, neither First Finance Ltd. nor Mr. Hromyk holds any derivative securities of the Issuer.
• The Reporting Persons (First Finance Ltd. and Mr. Hromyk) are supportive of the Merger Agreement.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily focused on a procedural update regarding a warrant cancellation in the context of a larger merger. The significant shareholding percentage remains a key factor.

Positives

• First Finance Ltd. and Andrew Hromyk maintain a controlling stake of 61.3% in ClearOne, Inc., indicating significant influence.
• The reporting persons are supportive of the ongoing merger agreement, suggesting alignment with the company's strategic direction.
• The cancellation of the warrant for no consideration simplifies the capital structure and removes potential dilution.

Negatives

• The filing details a warrant cancellation, which, while procedural, could be interpreted as a change in the investment strategy or a resolution of a prior agreement.
• The significant ownership concentration could limit liquidity for other shareholders if strategic decisions are heavily influenced by this single entity.

Risks

• The Reporting Persons reserve the right to change their plans and intentions at any time, which could introduce uncertainty for other stakeholders.
• The success of the merger with Cortigent, Inc. and Vivani Medical, Inc. is subject to various closing conditions and potential integration challenges.

Future Outlook

The filing does not provide specific forward-looking financial guidance. However, it indicates support for a merger agreement, which is a significant future event for the company.

Management Comments

• As the majority beneficial owner of the Issuer's common stock, the Reporting Persons are supportive of the Merger Agreement.
• The Reporting Persons reserve the right to change their plans and intentions at any time, as they deem appropriate.

Industry Context

StockSavvy.ai notes that this filing pertains to a Schedule 13D amendment, which typically signals a change in beneficial ownership or a shift in strategy by a significant shareholder. The context here is the cancellation of a warrant related to an ongoing merger, a common occurrence in corporate finance transactions. The high percentage of ownership by First Finance Ltd. suggests a potentially active role in the company's governance or strategic direction.

Related Party Transactions

• First Finance Ltd. entered into a Securities Purchase Agreement with ClearOne, Inc. on March 2, 2026, acquiring shares and a warrant.
• First Finance Ltd. entered into a Warrant Cancellation Agreement with ClearOne, Inc. on August 4, 2026, cancelling the warrant for no consideration.

Stakeholder Impact

• Shareholders: The continued significant ownership by First Finance Ltd. and their support for the merger may provide stability, but also concentration of control. The merger itself will impact all shareholders.
• Creditors: The merger and the financial health of the combined entity will affect creditors.
• Employees: The merger may lead to restructuring or changes in employment within the combined organization.

Next Steps

• The merger agreement between ClearOne, Inc., CLRO Merger Sub, Inc., Cortigent, Inc., and Vivani Medical, Inc. is expected to proceed.
• Cortigent, Inc. will survive the merger as a wholly-owned subsidiary of ClearOne, Inc.
• Vivani Medical, Inc. will receive 12,500,000 shares of ClearOne, Inc. common stock as merger consideration.

Key Dates

Recommendation

The filing is primarily procedural, updating the status of a warrant cancellation in the context of an ongoing merger. While the significant ownership stake is noted, there are no new financial results or strategic shifts presented that would warrant a buy or sell recommendation. A 'hold' reflects the neutral nature of this specific amendment.

Keywords

Schedule 13D, ClearOne Inc., First Finance Ltd., Andrew Hromyk, Warrant Cancellation, Merger Agreement, Cortigent Inc., Vivani Medical Inc.